![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
ABT-493 AND ABT-530 COMBINATION DEMONSTRATED MINIMAL POTENTIAL FOR CYP-MEDIATED DRUG-DRUG INTERACTIONS
|
|
|
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
Matthew P. Kosloski, Sandeep Dutta, David Pugatch, Hong Li, Federico Mensa, Jens Kort, Wei Liu AbbVie Inc., North Chicago, Illinois, United States
EASL: ABT-493 + ABT-530 at EASL - (05/05/16)
![EASL1](../images/051016/051016-1/EASL1.gif)
![EASL2](../images/051016/051016-1/EASL2.gif)
![EASL3](../images/051016/051016-1/EASL3.gif)
![EASL4](../images/051016/051016-1/EASL4.gif)
![EASL5](../images/051016/051016-1/EASL5.gif)
![EASL6](../images/051016/051016-1/EASL6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|